Showing results (81-90 of 392) with videos related to
Sort By:
Pageof 40
Hepato-Gastroenterology|October 26, 2011
Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitusTomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, et al.Journal of Medical Ultrasonics (2001)|November 16, 2024
Enhancing deep-seated hepatocellular carcinoma detection: assessing the added value of high mechanical index setting in sonazoid-based contrast-enhanced ultrasound during post-vascular phaseYing Zhang, Kazushi Numata, Hiromi Nihonmatsu, et al.BMC Gastroenterology|December 20, 2014
A screening instrument to identify ulcerative colitis patients with the high possibility of current non-adherence to aminosalicylate medication based on the Health Belief Model: a cross-sectional studyAki Kawakami, Makoto Tanaka, Masakazu Nishigaki, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|May 20, 2023
Impact of endoscopy intervals on metachronous gastric cancer after endoscopic submucosal dissection: Comparison between 1 year and half-a-yearYuichiro Ozeki, Kingo Hirasawa, Atsushi Sawada, et al.Gene|November 27, 2004
Functional variability of cagA gene in Japanese isolates of Helicobacter pyloriYoshihiro Hirata, Ayako Yanai, Wataru Shibata, et al.Cell|February 14, 2006
The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnoverLufen Chang, Hideaki Kamata, Giovanni Solinas, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytesTomoya Ohmae, Yoshihiro Hirata, Shin Maeda, et al.Journal of Gastroenterology and Hepatology|November 23, 2007
Clinical relevance of Helicobacter pylori sabA genotype in Japanese clinical isolatesAyako Yanai, Shin Maeda, Yoko Hikiba, et al.International Journal of Oncology|July 26, 2011
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancerWachiko Nakata, Yoku Hayakawa, Hayato Nakagawa, et al.Internal Medicine (Tokyo, Japan)|September 3, 2013
Efficacy of infliximab in patients with intestinal Behçet's disease refractory to conventional medicationHiroto Kinoshita, Reiko Kunisaki, Hisae Yamamoto, et al.Pageof 40